IP Library Granted Patent US 7,241,604
Granted Patent B1
US 7,241,604 · App. 10/800,024 · Granted Jul 10, 2007

Crystallization of 11-Beta-Hydroxysteroid Dehydrogenase type 1

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,604
App. No.
10/800,024
Granted
Jul 10, 2007
Kind
B1
Abstract

Provided are crystals relating to 11-Beta-Hydroxysteroid Dehydrogenase type 1 and its various uses.

Claims (10)

1. A composition comprising a protein in crystalline form wherein the protein consists of SEQ ID No: 5 and wherein the protein crystal has a crystal lattice in a P2 1 space group and unit cell dimensions, +/− 5% of a=56.4 Å, b=152.5 Å, c=73.8 Å, α=90°, β=92.2° and γ=90°.

2. A composition according to claim 1 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a resolution greater than 3.0 Angstroms.

3. A method for forming a crystal of a protein comprising:

forming a crystallization volume comprising a precipitant solution and a protein that consists of SEQ ID No: 5 and wherein the protein crystal has a crystal lattice in a P2 1 space group and unit cell dimensions, +/− 5% of a=56.4 Å, b=152.5 Å, c=73.8 Å, α=90°, β=92.2° and γ=90°; and storing the crystallization volume under conditions suitable for crystal formation of the protein.

4. A method according to claim 3 wherein the protein diffracts X-rays for a determination of structure coordinates to a resolution greater than 3.0 Angstroms.

5. A method according to claim 3 , the method further comprising diffracting the protein crystal to produce a diffraction pattern and solving the structure of the protein from the diffraction pattern.

6. A soluble protein consisting of SEQ ID No: 5.

7. A non-crystalline protein consisting of SEQ ID No: 5.

8. An isolated soluble protein consisting of SEQ ID No: 5.

9. An isolated non-crystalline protein consisting of SEQ ID No: 5.

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2004
From: AERTGEERTS, KATHLEEN; BRODSKY, OLEG; CHI, ELLEN; HILGERS, MARK T.; HOSFIELD, DADVID; SKENE, ROBERT J.
To: SYRRX, INC.
Reel/Frame 015456/0226 →